Italy Respiratory Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The market is segmented by Type (By Diagnostic and Monitoring Devices, By Therapeutic Devices, By Disposables).

Market Snapshot

CAGR
Study Period: 2018 - 2026
Base Year: 2020
CAGR: 6.8 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

  • The market for respiratory devices has been increasing in Sweden primarily due to the increasing prevalence of respiratory disorders, such as Chronic obstructive pulmonary disease (COPD), TB, Asthma, and Sleep Apnea. 
  • As per a report by Gianluigi Ferrante et al., published in the European Journal of Public Health 2017, the reported prevalence of Chronic Respiratory Diseases was 7%, with 3.4% asthma, 2.6% COPD, and 1.0% Asthma-COPD Overlap Syndrome. This has been the primary reason for the growth in demand for respiratory devices in Italy. Owing to the rapid advancements in the devices, the population has benefitted from the new and more effective technologies. This has propelled the growth of the market even further.
  • However, the high cost of devices and instruments has been restraining market growth.

Scope of the report

As per the scope of the report, respiratory devices include respiratory diagnostic devices, therapeutic devices, and breathing devices for administering long-term artificial respiration. It may also include a breathing apparatus used for resuscitation, by forcing oxygen into the lungs of a person who has undergone asphyxia.

By Type
By Diagnostic and Monitoring Devices
Spirometers
Sleep Test Devices
Other Diagnostic and Monitoring Devices
By Therapeutic Devices
Positive Airway Pressure (PAP) Devices
Humidifiers
Nebulizers
Ventilators
Inhalers
Other Therapeutic Devices
By Disposables

Report scope can be customized per your requirements. Click here.

Key Market Trends

Inhalers as Therapeutic devices are expected to Register High Growth in the Forecast Period

  • Chronic obstructive pulmonary disease (COPD) was the leading cause of death in Italy and is highly prevalent in the elderly population. As per a 2019 report by Francesco Blasi et al., published in the Journal of Human Vaccines & Immunotherapeutics, the prevalence of COPD could range from 3.3% in adults aged between 20 and 44 years to 13.3% in those aged between 65 and 84 years. Moreover, the geriatric population of Italy is also increasing, which is expected to exacerbate the problem.
  • Inhalers are a mainstay of treatment for the chronic obstructive pulmonary disease (COPD). These medications are inhaled through your mouth so they can directly reach your lungs. Usually, a combination of inhalers is prescribed. Using different types of inhalers can enhance treatment. As a result, inhalers for therapeutic administration are vital. As COPD is one of the leading causes of death in Italy, the demand for inhalers is expected to increase. This is expected to help the market growth.
Graph.png

Competitive Landscape

Italy is a developed country with well-structured healthcare system in the country. As a result, many global players in the Respiratory devices market are present in the country. Moreover, some domestic players have also been competing in the Italian market. These factors have made the region very competitive.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Prevalence of Respiratory Disorders, such as COPD, TB, Asthma, and Sleep Apnea

      2. 4.2.2 Technological Advancements and Increasing Applications in Homecare Setting

    3. 4.3 Market Restraints

      1. 4.3.1 High Cost of Devices

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Type

      1. 5.1.1 By Diagnostic and Monitoring Devices

        1. 5.1.1.1 Spirometers

        2. 5.1.1.2 Sleep Test Devices

        3. 5.1.1.3 Other Diagnostic and Monitoring Devices

      2. 5.1.2 By Therapeutic Devices

        1. 5.1.2.1 Positive Airway Pressure (PAP) Devices

        2. 5.1.2.2 Humidifiers

        3. 5.1.2.3 Nebulizers

        4. 5.1.2.4 Ventilators

        5. 5.1.2.5 Inhalers

        6. 5.1.2.6 Other Therapeutic Devices

      3. 5.1.3 By Disposables

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Dragerwerk AG

      2. 6.1.2 Fisher & Paykel Healthcare Ltd

      3. 6.1.3 Fosun Pharmaceutical (Breas Medical AB)

      4. 6.1.4 GE Healthcare

      5. 6.1.5 GlaxoSmithKline PLC

      6. 6.1.6 Invacare Corporation

      7. 6.1.7 Koninklijke Philips NV

      8. 6.1.8 Medtronic PLC

      9. 6.1.9 Smiths Medical Inc

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Italy Respiratory Devices Market market is studied from 2018 - 2026.

The Italy Respiratory Devices Market is growing at a CAGR of 6.8% over the next 5 years.

Fosun Pharmaceutical (Breas Medical AB), GE Healthcare, Fisher & Paykel Healthcare Ltd, Smiths Medical Inc, Medtronic PLC are the major companies operating in Italy Respiratory Devices Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!